On Pharma Importadora, Exportadora E Distribuidora De Medicamentos Ltda.

This study tests a new medicine called V-IMMUNE® in about 50 people aged 2 and older who have primary immunodeficiency (a weak immune system). Participants will receive V-IMMUNE® infusions every three weeks for one year. The goal is to see if it safely reduces serious bacterial i…

This study tests a medicine called V-IMMUNE® (a type of human immunoglobulin given through a vein) to see if it can safely raise platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risk. About 31 a…